bicalutamide and veliparib

bicalutamide has been researched along with veliparib in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Guan, X; Jin, J; Luo, J; Shi, Y; Sun, Z; Xu, J; Yang, F; Zhang, W1

Other Studies

2 other study(ies) available for bicalutamide and veliparib

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer.
    International journal of biological sciences, 2016, Volume: 12, Issue:12

    Topics: Anilides; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzimidazoles; Blotting, Western; BRCA1 Protein; Cell Line; Cell Line, Tumor; Cell Survival; Female; Flow Cytometry; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Poly (ADP-Ribose) Polymerase-1; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; Tosyl Compounds; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays

2016